Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 59
Filtrer
1.
Arch Oral Biol ; 61: 36-43, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26513680

RÉSUMÉ

OBJECTIVE: To investigate the potential effects of IFN-03A5 on the responsiveness of human gingival fibroblasts to bacterial challenge. DESIGN: mRNA and protein expression of CD14, TLR2 and TLR4 in human gingival fibroblasts was detected by quantitative polymerase chain reaction (Q-PCR) and flow cytometry. The effect of preincubation with IFN-03A5 on subsequent bacterial LPS-induced expression of IL-6 and IL-8 by gingival fibroblasts was determined by ELISA. Bacterial LPS-induced IκBα degradation in human gingival fibroblasts was investigated by western blot. RESULTS: Human gingival fibroblasts express CD14, TLR2 and TLR4 mRNAs. IFN-03A5, but not IL-103B2, induced mRNA expression of all three receptors and the expression of membrane bound CD14 protein. Pre-incubation of fibroblasts with IFN-03A5 and subsequent stimulation with Escherichia coli LPS or Porphyromonas gingivalis LPS led to increased production of IL-6 and IL-8. LPS-induced pro-inflammatory cytokine production was abrogated by a blocking antibody to CD14. Both E. coli LPS and P. gingivalis LPS induced IκBα degradation in human gingival fibroblasts. CONCLUSION: Our data indicate that IFN-03A5 primes human gingival fibroblasts, through the upregulation of CD14 expression, which results in increased responsiveness to bacterial LPS challenge, as determined by pro-inflammatory cytokine production.


Sujet(s)
Fibroblastes/effets des médicaments et des substances chimiques , Gencive/cytologie , Interféron gamma/pharmacologie , Antigènes CD14/métabolisme , Lipopolysaccharides/pharmacologie , ARN messager/métabolisme , Récepteur de type Toll-2/métabolisme , Récepteur de type Toll-4/métabolisme , Technique de Western , Cellules cultivées , Test ELISA , Escherichia coli/immunologie , Cytométrie en flux , Humains , Réaction de polymérisation en chaîne , Régulation positive
2.
J Clin Pharm Ther ; 40(2): 204-7, 2015 Apr.
Article de Anglais | MEDLINE | ID: mdl-25604860

RÉSUMÉ

WHAT IS KNOWN AND OBJECTIVE: Antibiotic resistance has become a global public health issue. Most antibiotics are prescribed in the community, although there is less stewardship of such agents in the community compared to secondary and tertiary care. Few studies have attempted to examine the prescribing practices in General Practice and its impact on antibiotic resistance and, therefore, a study was performed in order to compare antibiotic susceptibilities of commensal viridans group streptococci (VGS) obtained from patient cohorts in General Practices (GP), who were high and low prescribers of oral antibiotics. METHOD: Sixty-five patients (<1 month-81 years; 77% female: 23% male) were enrolled onto the study, and viridans group streptococci (n = 5/patient) were collected from each patient's nasal passages and oropharynx region and tested for antibiotic susceptibility against (i) tetracyclines (doxycycline); (ii) macrolides (erythromycin); (iii) ß-lactams (penicillin G); and (iv) fluoroquinolones (ofloxacin & levofloxacin). RESULTS AND DISCUSSION: There were no significant differences in MICs between high and low GP prescribers with doxycycline (P = 0·094), erythromycin (P = 0·122), ofloxacin (P = 0·193) and levofloxacin (P = 0·058). However, there was a significant difference between high and low GP practices with regard to penicillin G (P = 0·031). This finding is important as the ß-lactams are the most commonly prescribed oral antibiotic in the community. WHAT IS NEW AND CONCLUSION: This study demonstrates that high prescribing practices may lead to an altered (higher) level of resistance to these agents in the commensal VGS population, which may be important as reservoirs of antibiotic resistance determinants in subsequent horizontal gene transfer events, particularly with newly colonizing pathogens, including pneumococci. Primary care physicians should be aware that increased prescribing of antibiotics may led to increased level of penicillin resistance.


Sujet(s)
Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Résistance bactérienne aux médicaments , Médecine générale/statistiques et données numériques , Infections à streptocoques/traitement médicamenteux , Streptocoques viridans , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Fluoroquinolones/pharmacologie , Humains , Nourrisson , Nouveau-né , Macrolides/pharmacologie , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Types de pratiques des médecins , Tétracyclines/pharmacologie , Jeune adulte , bêta-Lactames/pharmacologie
4.
J Clin Pharm Ther ; 39(5): 468-70, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-24912052

RÉSUMÉ

WHAT IS KNOWN AND OBJECTIVE: To date, there is no evidence to indicate the reliability of how patients self-report their own antibiotic usage in the community. Such data are fundamental in supporting antimicrobial stewardship practices, and so there is a need to determine its accuracy and reliability. COMMENT: Patients in the community (n = 476) were required to recollect their antibiotic usage in the past three months. Simultaneously, similar information was obtained by careful extraction from their respective medical notes, which was qualitatively compared with the patient's recollection. Overall, concordance was high (88·1%), but age (<20 and >80 years) and sex (female) were significant factors of reliability. WHAT IS NEW AND CONCLUSION: This study suggests that basic self-reporting of antibiotic usage amongst patients is relatively reliable, with increasing accuracy with years until 80 years. Where such information is critical, the current study can help decide who to interview and whose notes to interrogate, in the quest to obtain reliable and accurate information.


Sujet(s)
Antibactériens/usage thérapeutique , Types de pratiques des médecins/statistiques et données numériques , Autorapport , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Antibactériens/effets indésirables , Antibactériens/ressources et distribution , Enfant , Enfant d'âge préscolaire , Services de santé communautaires , Résistance bactérienne aux médicaments , Femelle , Besoins et demandes de services de santé , Humains , Nourrisson , Nouveau-né , Mâle , Adulte d'âge moyen , Irlande du Nord , Reproductibilité des résultats
7.
Br J Biomed Sci ; 69(3): 123-5, 2012.
Article de Anglais | MEDLINE | ID: mdl-23057160

RÉSUMÉ

Streptococcus pneumoniae is the leading cause of community-acquired pneumonia (CAP). Currently, empirical treatment with quinolones is being used due to the emergence of beta-lactam and macrolide resistance in S. pneumonaie. Although the prevalence of quinolone-resistant S. pneumoniae remains low, increasing numbers of resistant isolates are being seen. Genetic mechanisms leading to fluoroquinolone resistance in pneumococci are complex. This study aims to use molecular methods to characterise all isolates through sequence analysis of their QRDR regions. Thirty-two S. pneumoniae isolates were obtained from nasal swabs from adult and paediatric patients attending local general practices in Northern Ireland. Phenotypic minimum inhibitory concentration (MIC) was determined for Clinical and Laboratory Standards Institute (CLSI) broth microdilution against ciprofloxacin, levofloxacin and norfloxacin. Simultaneously, the QRDR regions of gyrA, gyrB, parC and parE were analysed by sequence typing for all pneumococci obtained. Only one isolate (3.1%) showed reduced susceptibility to ciprofloxacin and levofloxacin. Two amino acid positions were discordant in the S. pneumoniae R6 strain and eight (25%) and 23 (71.9%) isolates contained the mutations Ile460Val in gyrA and Lys137Asn in parC (deposited in GenBank, accession numbers GQ999587-GQ999589), respectively. No mutations were found in either the gyrB or parE loci. In conclusion, the study demonstrated increased fluoroquinolone resistance which could not be accounted for simply through QRDR mutations, and, reciprocally, that mutations in the QRDR region do not necessarily result in overt phenotypic resistance.


Sujet(s)
DNA gyrase/génétique , DNA topoisomerase IV/génétique , Résistance bactérienne aux médicaments/génétique , Quinolinone/pharmacologie , Streptococcus pneumoniae/génétique , Adulte , Survie cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/génétique , Enfant , Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Humains , Tests de sensibilité microbienne , Mutation , Streptococcus pneumoniae/effets des médicaments et des substances chimiques
8.
Br J Biomed Sci ; 69(3): 119-22, 2012.
Article de Anglais | MEDLINE | ID: mdl-23057159

RÉSUMÉ

Inadvertent exposure of bacterial pathogens to X-ray radiation may be an environmental stress, where the bacterium may respond by increasing mutational events, thereby potentially resulting in increased antibiotic resistance and alteration to genotypic profile. In order to examine this, four clinical pathogens, including the Gram-negative organisms Escherichia coli O157:H7 NCTC12900 and Pseudomonas aeruginosa NCTC10662, as well as the Gram-positive organisms Staphylococcus aureus NCTC6571 and Enterococcus faecium were exposed to X-rays (35,495 cGy/cm2) over a seven-day period. Antibiotic susceptibility was assessed before, during and after exposure by examining susceptibility, as quantified by E-test with six antibiotics, as well as to a further 11 antibiotics by measurement of susceptibility zone sizes (mm). Additionally, the DNA profile of each organism was compared before, during and after exposure employing the enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC PCR). Results indicated that exposure of these organisms to this amount of X-ray radiation did not alter their antibiotic susceptibility, nor their genomic DNA profile. Overall, these data indicate that exposure of bacteria to X-ray radiation does not alter the test organisms' antibiotic susceptibility profiles, nor alter genomic DNA profiles of bacteria, which therefore does not compromise molecular epidemiological tracking of bacteria within healthcare environments in which patients have been exposed to X-ray radiation.


Sujet(s)
Antibactériens/pharmacologie , Bactéries/génétique , Bactéries/effets des radiations , ADN bactérien/génétique , ADN bactérien/effets des radiations , Résistance bactérienne aux médicaments/génétique , Résistance bactérienne aux médicaments/effets des radiations , Bactéries/effets des médicaments et des substances chimiques , Relation dose-effet des rayonnements , Génotype , Mutation/génétique , Mutation/effets des radiations , Dose de rayonnement
13.
Br J Biomed Sci ; 68(3): 109-11, 2011.
Article de Anglais | MEDLINE | ID: mdl-21950200

RÉSUMÉ

Forty-eight isolates of viridans-group streptococci (VGS) from adults and children in the community are examined for their resistance to ciprofloxacin phenotypically by determination of the minimum inhibitory concentration (MIC). In addition, the parC gene locus is amplified and sequenced in all isolates and mutations noted. Overall, 44 VGS organisms were found to be susceptible to ciprofloxacin by the broth microdilution method, and the remaining four strains had intermediate susceptibility. Reduced MICs were observed with intermediate strains when reserpine was added to the broth, inhibiting any efflux activity. Overall, the effect of adding reserpine to the broth medium was to add one doubling dilution to the MIC in the case of Streptococcus mitis, S. oralis and S. salivarius, as well as to increase the MIC by two doubling dilutions in two of the three S. parasanguinis isolates. Amino acid sequence analysis of the quinolone resistance-determining region (QRDR) of the parC gene locus showed good correlation to the phenotypic resistance to ciprofloxacin, where no confirmed mutation conferring quinolone resistance was found. Eleven amino acid positions showed discordance with S. pneumoniae R6 and eight (S52, F55, S58, N91, E135, K137, F141 and S167) were common in the VGS species examined. In addition, minor substitutions were found at three positions (D51, T54 and V86). In conclusion, this study demonstrates the low occurrence of ciprofloxacin resistance in a population of VGS isolated from the community. In addition, several silent mutations were noted in VGS organisms without any increase in MIC against ciprofloxacin.


Sujet(s)
Anti-infectieux/pharmacologie , Ciprofloxacine/pharmacologie , DNA topoisomerase IV/génétique , Résistance bactérienne aux médicaments/génétique , Streptocoques viridans/génétique , Adulte , Enfant d'âge préscolaire , Humains , Tests de sensibilité microbienne , Données de séquences moléculaires , Irlande du Nord , Quinolinone , Streptococcus pneumoniae/génétique , Streptocoques viridans/effets des médicaments et des substances chimiques
14.
Br J Biomed Sci ; 68(2): 65-8, 2011.
Article de Anglais | MEDLINE | ID: mdl-21706916

RÉSUMÉ

Clustered regulatory interspaced short palindromic repeats (CRISPRs) have been discovered in many bacteria and archaea. Many CRISPR-like sequences have been identified in an increasing number of studies on the function of CRISPRs. One CRISPR-like sequence of approximately 240 base pairs has been found to be highly conserved within 11 genome sequences of Streptococcus pneumoniae. A specific CRISPR-like polymerase chain reaction (PCR) assay was designed with the novel primers CRISPR 5F (forward primer) 5'-CTA ATY TCA TAA CCA TAR GAA TC-3' and CRISPR 3R (reverse primer) 5'-GAT AAR ATC CTY TAA WCT TCT AG-3' to detect the presence of this CRISPR-like sequence in pneumococci, as well as in viridans-group streptococci (VGS). This study investigates the prevalence of this CRISPR-like sequence in S. pneumoniae and 12 viridans-group streptococcal species and shows its existence to be shared by the majority of S. pneumoniae and, to a lesser extent, S. mitis. This CRISPR-like sequence was also found in S. australis and it is highly conserved among these strains, suggesting possible biological functional differences from true CRISPR because this CRISPR-like sequence has relatively few repeat numbers, and adjacent homology of CRISPR-associated (cas) genes was absent. The sharing of this CRISPR-like sequence between pneumococci, the mitis group and other VGS, as well as its high sequence homology, may suggest close evolutionary emergence of this sequence between these species.


Sujet(s)
ADN bactérien/génétique , Séquences répétées inversées/génétique , Streptococcus mitis/génétique , Séquence nucléotidique , Humains , Données de séquences moléculaires , Alignement de séquences , Spécificité d'espèce , Streptococcus pneumoniae/génétique
15.
Br J Biomed Sci ; 68(4): 190-6, 2011.
Article de Anglais | MEDLINE | ID: mdl-22263433

RÉSUMÉ

Viridans-group streptococci (VGS) consist of several taxa which historically have been highly diverse. However, at times it may become necessary to have a reliable scheme for the identification of these organisms to the species level. The aim of this study is to compare the ability of five gene loci, namely rnpB, 16S rRNA, 16S-23S rRNA, sodA and dnaJ, to speciate such organisms through a sequence typing-based approach. Reference organisms consisting of six VGS species were compared based on sequence typing, followed by comparison of 31 wild-type respiratory isolates, and showed that employment of sequence typing using the rnpB gene locus was the most specific and reliable. Therefore, the use of rnpB sequencing for the identification of VGS to species level is a reliable and feasible option, based on a single gene target.


Sujet(s)
Gènes bactériens/génétique , Infections à pneumocoques/diagnostic , Stomatite/diagnostic , Infections à streptocoques/diagnostic , Streptococcus pneumoniae/génétique , Streptocoques viridans/génétique , Humains , Phylogenèse , Infections à pneumocoques/microbiologie , ARN ribosomique 16S/génétique , ARN ribosomique 23S/génétique , Stomatite/microbiologie , Infections à streptocoques/microbiologie , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/isolement et purification , Streptocoques viridans/classification , Streptocoques viridans/isolement et purification
16.
Br J Biomed Sci ; 67(1): 1-4, 2010.
Article de Anglais | MEDLINE | ID: mdl-20373674

RÉSUMÉ

Methods employed by the World Health Organization (WHO) are used during this study to determine the optimum storage conditions for maintaining the culturability of Streptococcus pneumoniae in skimmed milk, tryptone, glucose and glycerin (STGG) transport medium. A comparison of S. pneumoniae strains sensitive and resistant to penicillin showed no significant difference in their survival ability in STGG medium. Furthermore, it is confirmed that storage at -70 degrees C remains most effective for maintaining viability by culture of S. pneumoniae. Storage at -20 degrees C would only be acceptable in the short-term, while storage at +4 degrees C is not recommended. Of note, this study has shown STGG medium at room temperature to be an efficient growth medium for pneumococci in the short-term. This work will help to establish robust sampling protocols when performing community studies to ensure culturability of comparison between community and laboratory pneumococci survival.


Sujet(s)
Antibactériens/pharmacologie , Pénicillines/pharmacologie , Streptococcus pneumoniae/effets des médicaments et des substances chimiques , Streptococcus pneumoniae/croissance et développement , Techniques bactériologiques , Milieux de culture , Résistance bactérienne aux médicaments , Humains , Tests de sensibilité microbienne , Transports
17.
Br Dent J ; 207(11): E22; discussion 542-3, 2009 Dec 12.
Article de Anglais | MEDLINE | ID: mdl-20010729

RÉSUMÉ

BACKGROUND: Smoking is correlated with a large number of oral conditions such as tooth staining and bad breath, periodontal diseases, impaired healing of wounds, precancer and oral cancer. These effects are often visible and in the early stages they are reversible after cessation of smoking. Dentists, as part of the health profession, are frequently in contact with the general population and there is evidence that they are as effective in providing smoking cessation counselling as any other healthcare group. AIMS AND METHODS: Patients' knowledge of the effects of smoking and their attitudes towards the role of dentists in smoking cessation activities were analysed via a self-completing questionnaire and compared depending on their smoking status (smokers and non-smokers). RESULTS: The results show that patients hold very positive attitudes towards dentists' role in smoking cessation. The results also show that although patients have a good knowledge of the effects of smoking on general health, smokers are significantly less aware of the relationship between smoking and gum disease and on wound healing. CONCLUSIONS: Dentists should inform their patients about the oral effects of smoking and strongly advise them not to smoke, especially in patients diagnosed with periodontal disease and requiring surgical procedures.


Sujet(s)
Attitude envers la santé , Dentistes , Connaissances, attitudes et pratiques en santé , Santé buccodentaire , Arrêter de fumer , Fumer/psychologie , Assistance , Études transversales , Relations dentiste-patient , Niveau d'instruction , Famille , Femelle , État de santé , Humains , Mâle , Situation de famille , Motivation , Maladies de la bouche/étiologie , Maladies parodontales/étiologie , Fumer/effets indésirables , Prévention du fait de fumer , Enquêtes et questionnaires , Cicatrisation de plaie/physiologie
20.
Br J Biomed Sci ; 64(2): 74-7, 2007.
Article de Anglais | MEDLINE | ID: mdl-17633142

RÉSUMÉ

A genus-specific polymerase chain reaction (PCR)-based assay is developed for the detection and identification of clinically relevant Fusobacterium species, including F. nucleatum and F. necrophorum. Two 16S ribosomal DNA (rDNA) primers, FUSO1 (forward primer: 5'-GAG AGA GCT TTG CGT CC-3' [17-mer]) and FUSO 2 (reverse primer: 5'-TGG GCG CTG AGG TTC GAC -3' [18-mer]) are designed to target conserved regions of the 16S rDNA gene for Fusobacterium spp. Subsequent proof-of-principle studies employing this assay detected Fusobacterium spp. in the faeces of eight (10%) out of 80 patients with suspected gastrointestinal infection. This assay may be used for the genus-specific detection of Fusobacterium spp. from clinical specimens and for subsequent species identification.


Sujet(s)
ADN ribosomique/analyse , Fusobacterium/génétique , Séquence nucléotidique , Femelle , Fusobacterium necrophorum/génétique , Fusobacterium nucleatum/génétique , Humains , Mâle , Données de séquences moléculaires , Réaction de polymérisation en chaîne/méthodes , ARN ribosomique 16S/génétique , Ribotypage/méthodes , Analyse de séquence d'ADN
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...